Pharmaceutical Launch Sequencing Trends: Designing Each Product Launch Sequence From Scratch RESEARCH TRIANGLE PARK, NC--(Marketwired - July 05, 2017) - About 81% of surveyed Top 10, Top 50, and small pharmaceutical and medical device firms build launch sequences from scratch for each...

Brazil, Russia, India, and China (BRIC) Becoming Popular Second Wave Targets, Recent Study Finds RESEARCH TRIANGLE PARK, NC--(Marketwired - May 10, 2017) - Emerging markets such as Brazil and India are becoming common second wave targets for pharmaceutical product launches, according to a recent...

Study Finds 88% of Pharma Companies Base Global Launch Planning on Regulatory Affairs Guidance RESEARCH TRIANGLE PARK, NC--(Marketwired - July 20, 2016) - A new benchmarking study published by Cutting Edge Information discovered that regulatory guidance is the most common tool that...

62% of Surveyed Pharma Companies Look to C-Suite for Final Sequencing Decisions RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2016) - Within pharmaceutical organizations, the ultimate responsibility for approving launch sequences among 62% of companies lies with C-level...

77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...